BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML
Main Authors: | , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society of Clinical Oncology
2020
|
_version_ | 1797071624946581504 |
---|---|
author | Ossenkoppele, G Vyas, P |
author_facet | Ossenkoppele, G Vyas, P |
author_sort | Ossenkoppele, G |
collection | OXFORD |
description | |
first_indexed | 2024-03-06T22:56:03Z |
format | Journal article |
id | oxford-uuid:606912bb-1074-4283-8d36-38ef9b1cc61e |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T22:56:03Z |
publishDate | 2020 |
publisher | American Society of Clinical Oncology |
record_format | dspace |
spelling | oxford-uuid:606912bb-1074-4283-8d36-38ef9b1cc61e2022-03-26T17:53:18ZBCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AMLJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:606912bb-1074-4283-8d36-38ef9b1cc61eEnglishSymplectic ElementsAmerican Society of Clinical Oncology2020Ossenkoppele, GVyas, P |
spellingShingle | Ossenkoppele, G Vyas, P BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML |
title | BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML |
title_full | BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML |
title_fullStr | BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML |
title_full_unstemmed | BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML |
title_short | BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML |
title_sort | bcl 2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia shifting from the unfit to the fit patient with aml |
work_keys_str_mv | AT ossenkoppeleg bcl2inhibitorandconventionalchemotherapycombinationsforacutemyeloidleukemiashiftingfromtheunfittothefitpatientwithaml AT vyasp bcl2inhibitorandconventionalchemotherapycombinationsforacutemyeloidleukemiashiftingfromtheunfittothefitpatientwithaml |